Cargando…

Intravenous immunoglobulins improve skin fibrosis in experimental models of systemic sclerosis

Systemic sclerosis (SSc) is the most severe systemic autoimmune disease with currently no cure. Intravenous immunoglobulins (IVIg) are an attractive candidate in this disease to counteract inflammation and fibrosis but data are scarce and conflicting. This study, assessed the effects of IVIg in a mu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Speca, Silvia, Farhat, Meryem-Maud, Jendoubi, Manel, Guerrier, Thomas, Sanges, Sébastien, Staumont-Sallé, Delphine, Hachulla, Eric, Dubucquoi, Sylvain, Sobanski, Vincent, Collet, Aurore, Launay, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497569/ https://www.ncbi.nlm.nih.gov/pubmed/37700078 http://dx.doi.org/10.1038/s41598-023-42464-9

Ejemplares similares

Soluble markers of B cell activation suggest a role of B cells in the pathogenesis of systemic sclerosis-associated pulmonary arterial hypertension
por: Sanges, Sébastien, et al.
Publicado: (2022)

B Cell Homeostasis and Functional Properties Are Altered in an Hypochlorous Acid-Induced Murine Model of Systemic Sclerosis
por: Sanges, Sébastien, et al.
Publicado: (2017)

Simple gene signature to assess murine fibroblast polarization
por: Ledoult, Emmanuel, et al.
Publicado: (2022)

Association between Routine Laboratory Parameters and the Severity and Progression of Systemic Sclerosis
por: Chikhoune, Liticia, et al.
Publicado: (2022)

Effects of Immunoglobulins G From Systemic Sclerosis Patients in Normal Dermal Fibroblasts: A Multi-Omics Study
por: Chepy, Aurélien, et al.
Publicado: (2022)

ABO Blood Groups in Systemic Sclerosis: Distribution and Association with This Disease’s Characteristics
por: Collet, Aurore, et al.
Publicado: (2022)

Can Antinuclear Antibodies Have a Pathogenic Role in Systemic Sclerosis?
por: Chepy, Aurélien, et al.
Publicado: (2022)

Pulmonary hypertension in systemic sclerosis: different phenotypes
por: Launay, David, et al.
Publicado: (2017)

Activities of Clinical Expertise and Research in a Rare Disease Referral Centre: A Place for Telemedicine beyond the COVID-19 Pandemic?
por: Ducrocq, Quentin, et al.
Publicado: (2023)

Acquired Hemophilia A in IgG4-Related Disease: Case Report, Immunopathogenic Study, and Review of the Literature
por: Sanges, Sébastien, et al.
Publicado: (2020)

Prevalence and Clinical Associations of Antiphospholipid Antibodies in Systemic Sclerosis: New Data From a French Cross-Sectional Study, Systematic Review, and Meta-Analysis
por: Sobanski, Vincent, et al.
Publicado: (2018)

Raising rare disease awareness using red flags, role play simulation and patient educators: results of a novel educational workshop on Raynaud phenomenon and systemic sclerosis
por: Sanges, S., et al.
Publicado: (2020)

Effect of In Vitro and In Vivo Anakinra on Cytokines Production in Schnitzler Syndrome
por: Launay, David, et al.
Publicado: (2013)

Mild pulmonary hemodynamic alterations in patients with systemic sclerosis: relevance of the new 2022 ESC/ERS definition of pulmonary hypertension and impact on mortality
por: Puigrenier, Sébastien, et al.
Publicado: (2022)

Factors associated with the 6-minute walk distance in patients with systemic sclerosis
por: Sanges, Sébastien, et al.
Publicado: (2017)

Activités de recours et de recherche d’un service de Médecine Interne : une place pour la télémédecine, au-delà de la pandémie COVID-19 ?
por: Ducrocq, Q., et al.
Publicado: (2021)

Self-reported Impact of the Early 2020 COVID-19 Crisis on the Healthcare Pathway During and After Lockdown in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Practical Survey
por: Nasseh, Jessica, et al.
Publicado: (2022)

Antibody-mediated neutralization of galectin-3 as a strategy for the treatment of systemic sclerosis
por: Ortega-Ferreira, Céline, et al.
Publicado: (2023)

Proinflammatory B-cell profile in the early phases of MS predicts an active disease
por: Guerrier, Thomas, et al.
Publicado: (2017)

The Role of Intravenous Immunoglobulin Preparations in the Treatment of Systemic Sclerosis
por: Baleva, Marta, et al.
Publicado: (2011)

General Burden of Adult Atopic Dermatitis: An Observational Study of Disease Perceptions among Patients and Dermatologists in France
por: SORIA, Angèle, et al.
Publicado: (2021)

The Atopic Dermatitis Control Tool: A High-Performance Tool for Optimal Support
por: STAUMONT-SALLÉ, Delphine, et al.
Publicado: (2021)

Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease
por: Le Gouellec, Noémie, et al.
Publicado: (2017)

Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis
por: Sobanski, Vincent, et al.
Publicado: (2019)

An Optimized Fluorescence-Based Bidimensional Immunoproteomic Approach for Accurate Screening of Autoantibodies
por: Dutoit-Lefèvre, Virginie, et al.
Publicado: (2015)

(18)F-FDG positron emission tomography scanning in systemic sclerosis-associated interstitial lung disease: a pilot study
por: Ledoult, Emmanuel, et al.
Publicado: (2021)

Pyoderma gangrenosum developing in a patient treated with dupilumab
por: Nasseh, Jessica, et al.
Publicado: (2021)

INTRAVENOUS IMMUNOGLOBULIN IN DERMATOLOGY
por: Dhar, Sandipan
Publicado: (2009)

Clinical Characteristics and Outcome of Patients with Infective Endocarditis Diagnosed in a Department of Internal Medicine
por: Kreitmann, Louis, et al.
Publicado: (2020)

Efficacy of immunosuppressants with bridge vasodilator therapy in severe lupus erythematosus‐associated pulmonary arterial hypertension
por: Sanges, Sébastien, et al.
Publicado: (2019)

Safety of Intravenous Immunoglobulin (Tegeline®), Administered at Home in Patients with Autoimmune Disease: Results of a French Study
por: Hachulla, Eric, et al.
Publicado: (2018)

Rapid improvement of systemic sclerosis-associated intestinal pseudo-obstruction with intravenous immunoglobulin administration
por: Matsuda, Kazuki M, et al.
Publicado: (2023)

Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis
por: Launay, David, et al.
Publicado: (2018)

Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database
por: Scanvion, Quentin, et al.
Publicado: (2020)

Relevance of Partitioning DLCO to Detect Pulmonary Hypertension in Systemic Sclerosis
por: Sivova, Nadia, et al.
Publicado: (2013)

Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients
por: Hachulla, A-L, et al.
Publicado: (2009)

Invasive Group A Streptococcal Infections: Benefit of Clindamycin, Intravenous Immunoglobulins and Secondary Prophylaxis
por: Laho, Delphine, et al.
Publicado: (2021)

Vascular skin manifestations in patients with severe COVID-19 in intensive care units: a monocentric prospective study
por: Dezoteux, Frédéric, et al.
Publicado: (2021)

Intravenous Immunoglobulin in the Management of Lupus Nephritis
por: Wenderfer, Scott E., et al.
Publicado: (2012)

Pemphigoid gestationis and intravenous immunoglobulin therapy()
por: Yang, Anes, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4pqdkua2mhr6injvr2l1k3qc97